NEW YORK -- (Business Wire)
Biochem, Inc. (NYSE: ENZ), will hold a conference call to discuss
fiscal 2013 first quarter results on Tuesday, December 11, 2012, at 8:30
To listen to the conference call dial 1-888-459-5609. International
callers can dial 1-973-321-1024. When prompted, use PIN number 78041681.
Dial in approximately ten minutes prior to the scheduled teleconference
time. A rebroadcast of the call will be available starting approximately
two hours after the conference call ends, through midnight (E.T.)
Tuesday, December 25, 2012. The replay of the conference call can be
accessed by dialing 1-800-585-8367 (International callers can dial
1-404-537-3406) and, when prompted, use the same PIN number 78041681.
Enzo’s conference call can also be accessed live over the Internet at http://phoenix.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=94391&eventID=4879258.
To listen to the live call, individuals should go to the web site at
least 15 minutes early to register, download and install any necessary
audio software. Any pop up blocker installed on your PC should be
disabled while accessing the webcast.
A press release announcing first quarter results will be distributed
Monday, December 10, 2012 after the market close.
Enzo Biochem is engaged in the research, development and manufacture of
innovative health care products based on molecular biology and genetic
engineering techniques, and in providing diagnostic services to the
Except for historical information, the matters discussed in this news
release may be considered "forward-looking" statements within the
meaning of Section 27A of the Securities Act of 1933, as amended and
Section 21E of the Securities Exchange Act of 1934, as amended. Such
statements include declarations regarding the intent, belief or current
expectations of the Company and its management, including those related
to cash flow, gross margins, revenues, and expenses are dependent on a
number of factors outside of the control of the company including, inter
alia, the markets for the Company’s products and services, costs of
goods and services, other expenses, government regulations, litigations,
and general business conditions. See Risk Factors in the Company’s Form
10-K for the fiscal year ended July 31, 2010. Investors are cautioned
that any such forward-looking statements are not guarantees of future
performance and involve a number of risks and uncertainties that could
materially affect actual results. The Company disclaims any obligations
to update any forward-looking statement as a result of developments
occurring after the date of this press release.
Enzo Biochem, Inc.
Steve Anreder, 212-532-3232
Michael Wachs, 212-732-4300
Source: Enzo Biochem, Inc.
© 2017 Canjex Publishing Ltd. All rights reserved.